Clinica de Oncologia de Porto Alegre - CliniOnco
Porto Alegre, RS, Brazil
Cancer treatment center in Porto Alegre, State of Rio Grande do Sul
Rua Dona Laura, 226 - Rio Branco, Porto Alegre - RS, 90430-090
About Clinica de Oncologia de Porto Alegre - CliniOnco
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Genentech, Inc.
1
Helsinn Healthcare SA
1
Morphotek
1
Clinical Trials at Clinica de Oncologia de Porto Alegre - CliniOnco
During the past decade, Clinica de Oncologia de Porto Alegre - CliniOnco conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.
2008-07-29
2019-04-30
Completed
154
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
2008-10-16
2029-09-20
Recruiting
720
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
2009-04-16
2013-04-12
Terminated
1,100
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
2010-07-31
2016-09-16
Completed
1,095
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
2011-04-01
Completed
1,455
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
2012-09-03
2016-04-30
Terminated
415
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
2012-08-27
2017-11-21
Completed
481
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
2012-09-24
2018-07-13
Completed
498
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica de Oncologia de Porto Alegre - CliniOnco"
#1 collaborator was "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Clinica de Oncologia de Porto Alegre - CliniOnco
According to Clinical.Site data, the most researched conditions in "Clinica de Oncologia de Porto Alegre - CliniOnco" are
"Breast Cancer" (1 trials), "Chemotherapy-Induced Nausea and Vomiting" (1 trials), "Gastric Cancer" (1 trials), "Melanoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Clinica de Oncologia de Porto Alegre - CliniOnco" in a lesser frequency.
Clinical Trials Intervention Types at Clinica de Oncologia de Porto Alegre - CliniOnco
Most popular intervention types in "Clinica de Oncologia de Porto Alegre - CliniOnco" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (2 trials), "Placebo" (2 trials), "Taxane" (2 trials), "trastuzumab emtansine" (2 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinica de Oncologia de Porto Alegre - CliniOnco
The vast majority of trials in "Clinica de Oncologia de Porto Alegre - CliniOnco" are
7 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Clinica de Oncologia de Porto Alegre - CliniOnco
Currently, there are NaN active trials in "Clinica de Oncologia de Porto Alegre - CliniOnco".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Clinica de Oncologia de Porto Alegre - CliniOnco,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Clinica de Oncologia de Porto Alegre - CliniOnco, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".